Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-12 4:11 pm Sale | 13G | Intersect ENT Inc. XENT | HealthCor Management L.P. | 0 0% | -2,536,760 (Position Closed) | View |
2021-02-12 4:10 pm Sale | 13G | MADRIGAL PHARMACEUTICALS INC. MDGL | HealthCor Management L.P. | 902,601 5.8% | -185,709 (-17.06%) | View |
2021-02-12 4:10 pm Sale | 13G | ViewRay Inc. VRAY | HealthCor Management L.P. | 0 0% | -9,477,799 (Position Closed) | View |
2021-02-12 4:10 pm Sale | 13G | NEVRO CORP NVRO | HealthCor Management L.P. | 156,046 0.5% | -1,591,574 (-91.07%) | View |
2021-02-12 4:09 pm Purchase | 13G | Aurinia Pharmaceuticals Inc. AUPH | HealthCor Management L.P. | 6,937,448 5.5% | 1,116,808 (+19.19%) | View |
2021-02-12 4:09 pm Sale | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | HealthCor Management L.P. | 0 0% | -1,584,466 (Position Closed) | View |
2021-01-05 4:00 pm Purchase | 13D | CareView Communications Inc CRVW | HealthCor Management L.P. | 50,183,006 26.5% | 1,300,255 (+2.66%) | View |
2020-10-02 4:00 pm Purchase | 13D | CareView Communications Inc CRVW | HealthCor Management L.P. | 48,882,751 26% | 1,263,687 (+2.65%) | View |
2020-09-11 4:00 pm Purchase | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | HealthCor Management L.P. | 1,584,466 6.5% | 1,584,466 (New Position) | View |
2020-07-02 4:01 pm Purchase | 13D | CareView Communications Inc CRVW | HealthCor Management L.P. | 47,619,064 25.5% | 1,228,163 (+2.65%) | View |
2020-03-27 07:00 am Purchase | 13G | NEVRO CORP NVRO | HealthCor Management L.P. | 1,747,620 5.5% | 1,747,620 (New Position) | View |
2020-02-14 08:01 am Purchase | 13G | Intersect ENT Inc. XENT | HealthCor Management L.P. | 2,536,760 8% | 46,650 (+1.87%) | View |
2020-02-14 08:01 am Purchase | 13G | ViewRay Inc. VRAY | HealthCor Management L.P. | 9,477,799 6.4% | 4,423,219 (+87.51%) | View |
2020-02-14 08:00 am Sale | 13G | Radius Health Inc. RDUS | HealthCor Management L.P. | 0 0% | -3,723,949 (Position Closed) | View |
2020-02-14 08:00 am Sale | 13G | PACIRA BIOSCIENCES INC PCRX | HealthCor Management L.P. | 771,140 1.8% | -1,726,988 (-69.13%) | View |
2020-02-14 08:00 am Purchase | 13G | MADRIGAL PHARMACEUTICALS INC. MDGL | HealthCor Management L.P. | 1,088,310 7.1% | 288,310 (+36.04%) | View |
2020-02-14 08:00 am Sale | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | HealthCor Management L.P. | 0 0% | -4,613,280 (Position Closed) | View |
2020-02-10 4:03 pm Purchase | 13D | CareView Communications Inc CRVW | HealthCor Management L.P. | 46,390,901 25% | 8,498,118 (+22.43%) | View |
2020-01-27 4:23 pm Purchase | 13G | Aurinia Pharmaceuticals Inc. AUPH | HealthCor Management L.P. | 5,820,640 5.4% | 5,820,640 (New Position) | View |
2020-01-02 4:03 pm Purchase | 13D | CareView Communications Inc CRVW | HealthCor Management L.P. | 37,892,783 21.4% | 1,604,221 (+4.42%) | View |